Home > News > After a pause, buckyballs make it to the big time
October 17th, 2003
After a pause, buckyballs make it to the big time
Buckyballs, the soccer ball-shaped molecules that helped kick-start interest in nanoscale science and technology in the 1990s, finally made the big time. The biotech startup C Sixty announced Thursday that it is partnering with the pharmaceutical company Merck & Co. to develop drugs based on buckyballs, formally known as buckminsterfullerenes. If they are successful, fullerenes could find a use that is both medically beneficial and lucrative, and open the door for high-volume production of fullerenes.
Chicago Awareness Organization First Not-for-Profit to Sponsor Dog Training to Detect Ovarian Cancer Odorants December 12th, 2013
Iranian Scientists Discover New Electrical Device for Rapid Diagnosis of Cancer December 12th, 2013
Arrowhead to Report Fiscal 2013 Fourth Quarter and Year-End Financial Results - Conference Call Scheduled for Wednesday, December 18, 2013 December 12th, 2013
Countdown to zero: New 'zero-dimensional' carbon nanotube may lead to superthin electronics and synt December 11th, 2013